Insider Trading activities of Biomarin Pharmaceutical Inc (BMRN)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biomarin Pharmaceutical Inc (BMRN) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biomarin Pharmaceutical Inc since year 2005. Table 2 shows the detailed insider transactions of Biomarin Pharmaceutical Inc since 2005. The reporting company's ticker symbol is BMRN. The reporting company's CIK number is 1048477.
The total value of stock buying since 2005 is $1,114,124.
The total value of stock sales since 2005 is $448,939,573.
The total value of stock option exercises since 2005 is $124,585,569.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Biomarin Pharmaceutical Inc (BMRN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-11 0 $0 13,190 $1,030,115 10,000 $215,100
2019-10 0 $0 5,000 $347,750 5,000 $107,550
2019-09 0 $0 3,750 $279,262 4,750 $102,172
2019-08 0 $0 0 $0 1,553 $97,994
2019-06 0 $0 3,750 $304,050 3,750 $80,662
2019-05 0 $0 18,000 $1,481,702 18,000 $259,020
2019-04 0 $0 29,426 $2,641,035 15,000 $222,970
2019-03 0 $0 67,148 $6,135,738 28,150 $405,078
2019-02 0 $0 15,000 $1,412,800 15,000 $215,850
2019-01 0 $0 19,000 $1,748,866 19,000 $273,410
2018-12 0 $0 13,150 $1,123,079 13,150 $203,108
2018-11 0 $0 14,500 $1,353,993 14,500 $652,250
2018-10 0 $0 2,500 $248,025 3,500 $55,570
2018-09 0 $0 21,866 $2,167,689 19,650 $394,768
2018-08 0 $0 43,873 $4,394,628 22,500 $323,775
2018-07 0 $0 1,500 $152,535 1,500 $26,790
2018-06 0 $0 56,701 $5,302,730 43,590 $1,141,986
2018-05 0 $0 115,259 $10,245,265 127,500 $4,920,222
2018-04 0 $0 56,928 $4,683,380 45,750 $1,650,942
2018-03 0 $0 48,150 $4,012,735 36,000 $1,247,510
2018-02 0 $0 40,000 $3,565,970 40,000 $1,543,600
2018-01 0 $0 28,750 $2,574,754 28,750 $1,010,237
2017-12 0 $0 20,800 $1,866,156 20,000 $771,800
2017-11 0 $0 1,200 $102,766 0 $0
2017-09 0 $0 40,686 $3,733,519 22,271 $756,233
2017-06 0 $0 56,740 $5,196,678 55,504 $1,546,659
2017-05 0 $0 47,193 $4,376,722 50,655 $1,010,627
2017-04 0 $0 10,000 $948,600 13,000 $216,468
2017-03 0 $0 55,418 $5,104,844 33,500 $850,550
2017-02 0 $0 45,000 $4,139,850 45,000 $2,290,350
2017-01 0 $0 31,000 $2,724,720 26,000 $450,578
2016-12 0 $0 8,000 $668,760 8,000 $138,640
2016-11 0 $0 368,657 $31,735,869 348,657 $8,157,575
2016-10 0 $0 225,791 $18,849,073 225,791 $4,704,174
2016-09 0 $0 262,085 $24,730,339 243,618 $7,498,354
2016-08 0 $0 63,120 $5,880,505 56,666 $1,128,171
2016-07 0 $0 51,333 $4,771,291 51,822 $963,289
2016-06 0 $0 129,397 $10,443,194 124,998 $2,192,463
2016-05 0 $0 145,768 $12,305,697 138,396 $3,224,252
2016-04 0 $0 0 $0 3,000 $43,170
2016-03 0 $0 17,874 $1,523,767 0 $0
2016-02 0 $0 7,500 $600,000 7,500 $289,425
2015-12 0 $0 1,362 $136,200 0 $0
2015-11 0 $0 36,076 $3,775,304 35,000 $1,200,599
2015-10 0 $0 1,000 $108,241 0 $0
2015-09 0 $0 1,000 $131,432 15,000 $322,650
2015-08 0 $0 1,500 $202,083 0 $0
2015-07 0 $0 4,500 $658,599 3,000 $189,300
2015-06 0 $0 9,197 $1,132,782 0 $0
2015-05 0 $0 144,799 $17,960,963 56,849 $1,173,278
2015-04 0 $0 26,052 $3,140,125 22,546 $145,647
2015-03 0 $0 183,803 $20,976,250 163,051 $3,632,357
2015-01 0 $0 2,000 $188,286 0 $0
2014-12 0 $0 38,450 $3,486,374 36,450 $955,257
2014-11 0 $0 53,447 $4,697,929 46,000 $1,037,940
2014-10 0 $0 94,425 $7,692,840 94,425 $2,718,809
2014-09 0 $0 33,554 $2,341,703 33,536 $1,002,159
2014-08 0 $0 17,229 $1,137,651 15,000 $280,050
2014-07 0 $0 2,229 $142,656 0 $0
2014-06 0 $0 2,377 $144,200 0 $0
2014-05 0 $0 14,517 $835,233 0 $0
2014-03 0 $0 25,382 $2,009,360 27,370 $770,451
2014-02 0 $0 38,000 $2,916,970 34,000 $697,260
2014-01 0 $0 20,916 $1,431,756 20,000 $259,800
2013-12 0 $0 92,426 $6,437,860 74,526 $1,970,425
2013-11 0 $0 5,099 $318,032 10,000 $129,900
2013-10 0 $0 15,000 $962,902 12,000 $155,880
2013-09 0 $0 51,000 $3,729,064 51,000 $1,028,720
2013-08 0 $0 1,000 $64,364 1,000 $12,990
2013-07 0 $0 14,066 $843,061 12,000 $187,188
2013-06 0 $0 1,591 $92,799 45,000 $1,679,849
2013-05 0 $0 243,590 $16,594,563 225,831 $4,603,936
2013-04 0 $0 49,102 $3,137,955 48,102 $693,782
2013-03 0 $0 71,141 $4,305,011 68,126 $1,078,025
2013-02 0 $0 77,003 $4,327,513 75,503 $1,232,701
2013-01 0 $0 121,324 $6,578,490 107,324 $2,326,181
2012-12 0 $0 62,415 $3,038,034 54,756 $741,033
2012-11 0 $0 409,971 $19,513,489 370,722 $6,587,545
2012-10 0 $0 39,665 $1,658,284 36,665 $544,056
2012-09 0 $0 16,665 $647,721 15,665 $187,597
2012-08 0 $0 47,665 $1,797,044 37,665 $535,017
2012-07 0 $0 118,281 $4,739,697 118,281 $1,977,035
2012-06 0 $0 7,665 $274,180 8,915 $109,964
2012-05 0 $0 265,671 $9,928,453 267,703 $3,409,494
2012-04 0 $0 36,544 $1,270,139 26,853 $285,655
2012-03 0 $0 17,855 $618,010 16,855 $130,291
2012-02 0 $0 218,703 $7,691,550 237,703 $3,228,885
2012-01 0 $0 6,854 $238,583 6,854 $96,823
2011-12 0 $0 1,854 $62,646 1,854 $33,223
2011-11 0 $0 4,615 $151,482 4,355 $69,216
2011-10 0 $0 39,607 $1,354,767 39,607 $626,028
2011-09 0 $0 23,733 $749,111 22,733 $391,565
2011-08 0 $0 53,577 $1,607,974 49,577 $532,560
2011-07 0 $0 50,866 $1,504,767 49,866 $807,320
2011-06 0 $0 4,472 $119,418 16,895 $32,784
2011-05 0 $0 99,608 $2,702,288 108,058 $1,446,241
2011-04 0 $0 21,819 $581,565 13,654 $167,147
2011-03 0 $0 7,772 $189,100 7,772 $93,152
2011-02 0 $0 18,912 $476,175 18,912 $147,194
2011-01 0 $0 5,271 $139,653 1,771 $22,701
2010-12 0 $0 12,313 $341,988 12,313 $131,902
2010-11 0 $0 126,394 $3,294,091 111,437 $1,381,669
2010-10 0 $0 82,479 $2,094,260 82,479 $1,091,944
2010-09 0 $0 48,709 $1,072,279 38,709 $453,555
2010-08 0 $0 25,490 $526,953 19,833 $184,744
2010-07 0 $0 3,333 $69,160 3,333 $44,691
2010-06 0 $0 1,676 $32,910 26,084 $9,215
2010-05 0 $0 4,072 $90,417 32,834 $27,083
2010-04 0 $0 7,082 $169,970 7,082 $82,305
2010-03 0 $0 231,894 $5,167,130 190,478 $3,813,628
2010-02 800 $16,062 377 $7,917 377 $4,425
2010-01 0 $0 21,143 $443,625 20,143 $285,149
2009-12 0 $0 22,500 $390,494 21,000 $154,140
2009-08 0 $0 4,177 $66,464 177 $1,085
2009-07 0 $0 456 $6,332 1,250 $0
2009-06 3,500 $49,180 2,863 $41,528 16,750 $0
2009-03 13,000 $136,474 7,897 $92,394 7,897 $50,777
2009-02 10,000 $120,780 17,000 $325,363 17,000 $109,310
2009-01 0 $0 19,679 $354,645 19,679 $140,038
2008-12 6,400 $105,495 28,177 $454,898 17,177 $105,295
2008-11 0 $0 75,177 $1,201,645 33,177 $401,111
2008-10 503 $6,716 18,177 $476,456 18,177 $111,425
2008-09 0 $0 31,996 $974,263 19,996 $323,338
2008-08 0 $0 20,469 $648,787 7,019 $62,349
2008-07 0 $0 70,646 $2,103,891 41,996 $585,158
2008-06 0 $0 28,143 $1,024,770 36,143 $290,735
2008-05 0 $0 112,176 $4,266,543 94,300 $844,289
2008-04 9,849 $105,960 115,479 $4,207,078 153,057 $799,223
2008-03 0 $0 489,028 $17,346,767 397,956 $3,672,988
2008-02 0 $0 147,462 $5,572,934 118,625 $1,063,920
2008-01 0 $0 35,490 $1,282,494 35,490 $245,758
2007-12 0 $0 21,114 $753,542 21,114 $171,399
2007-11 0 $0 2,365 $61,052 2,365 $26,383
2007-10 4,695 $32,483 51,371 $1,319,911 51,371 $450,827
2007-09 0 $0 238,442 $5,460,778 171,149 $1,143,929
2007-08 0 $0 127,019 $2,584,367 135,019 $945,187
2007-07 0 $0 14,500 $263,818 12,500 $50,000
2007-06 0 $0 16,045 $291,731 11,045 $73,043
2007-05 0 $0 18,500 $313,556 15,000 $96,900
2007-04 12,892 $74,852 19,000 $332,353 17,500 $82,300
2007-03 0 $0 13,500 $221,188 0 $0
2007-02 0 $0 42,000 $777,820 28,000 $187,090
2007-01 0 $0 12,500 $203,700 12,500 $50,000
2006-12 2,100 $37,554 14,500 $261,000 14,500 $117,450
2006-11 0 $0 17,500 $285,125 17,500 $85,800
2006-10 12,893 $60,411 0 $0 0 $0
2006-08 2,500 $37,100 98,500 $1,526,147 128,500 $929,790
2006-07 1,500 $21,658 0 $0 20,000 $94,400
2006-06 1,500 $19,575 0 $0 0 $0
2006-05 5,500 $67,657 0 $0 0 $0
2006-04 1,500 $20,010 0 $0 0 $0
2006-03 1,500 $19,489 28,000 $391,000 28,000 $188,670
2006-02 5,000 $62,940 23,500 $286,280 23,500 $132,650
2006-01 1,500 $16,177 2,500 $30,500 52,500 $217,500
2005-12 2,500 $25,145 40,571 $420,417 0 $0
2005-11 1,500 $12,554 40,571 $405,710 0 $0
2005-10 3,500 $27,265 0 $0 0 $0
2005-09 4,500 $38,587 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Biomarin Pharmaceutical Inc insiders (BMRN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-11-26 Davis George Eric (EVP, General Counsel) Sale 3,190 79.66 254,115
2019-11-22 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 77.60 776,000
2019-11-22 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 21.51 215,100
2019-10-25 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 69.55 347,750
2019-10-25 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 21.51 107,550
2019-09-27 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 21.51 21,510
2019-09-17 Lawlis V Bryan Sale 3,750 74.47 279,262
2019-09-17 Lawlis V Bryan Option Ex 3,750 21.51 80,662
2019-08-07 Heron Elaine J Option Ex 1,553 63.10 97,994
2019-06-17 Lawlis V Bryan Sale 3,750 81.08 304,050
2019-06-17 Lawlis V Bryan Option Ex 3,750 21.51 80,662
2019-05-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 82.52 825,190
2019-05-10 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 14.39 143,900
2019-05-09 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 81.97 327,888
2019-05-09 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2019-05-08 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 82.16 328,624
2019-05-08 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2019-04-26 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 83.48 250,437
2019-04-26 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 14.39 43,170
2019-04-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 21.51 21,510
2019-04-12 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 89.12 356,480
2019-04-12 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2019-04-11 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 14.39 14,390
2019-04-08 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 92.44 277,326
2019-04-08 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 14.39 43,170
2019-04-05 Mueller Brian (SVP, Corporate Controller) Sale 2,953 94.00 277,582
2019-04-05 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 93.37 280,113
2019-04-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 14.39 43,170
2019-04-01 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 13,473 89.00 1,199,097
2019-03-27 Lawlis V Bryan Sale 2,150 89.76 192,984
2019-03-27 Lawlis V Bryan Option Ex 2,150 14.39 30,938
2019-03-27 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 100 90.00 9,000
2019-03-27 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 14.39 14,390
2019-03-26 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 3,656 89.17 326,023
2019-03-25 Davis George Eric (EVP, General Counsel) Sale 3,363 87.86 295,473
2019-03-25 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 87.86 351,440
2019-03-25 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2019-03-25 Fuchs Henry J (President, Worldwide R&D) Sale 5,932 87.86 521,185
2019-03-21 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 4,519 90.05 406,917
2019-03-19 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 3,728 93.07 346,964
2019-03-19 Davis George Eric (EVP, General Counsel) Sale 7,907 93.92 742,625
2019-03-19 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 14.39 14,390
2019-03-18 Fuchs Henry J (President, Worldwide R&D) Sale 9,597 94.09 902,981
2019-03-15 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 94.40 377,600
2019-03-15 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2019-03-13 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 93.42 280,254
2019-03-13 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 14.39 43,170
2019-03-12 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 91.44 365,772
2019-03-12 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2019-03-11 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 88.96 444,780
2019-03-11 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 14.39 71,950
2019-03-07 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 90.78 363,120
2019-03-07 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2019-03-04 Fuchs Henry J (President, Worldwide R&D) Sale 2,196 95.00 208,620
2019-02-27 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 91.78 367,120
2019-02-27 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2019-02-21 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 90.12 270,360
2019-02-21 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 14.39 43,170
2019-02-14 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 95.20 380,800
2019-02-14 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2019-02-05 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 98.63 394,520
2019-02-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2019-01-22 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 96.82 290,460
2019-01-22 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 14.39 43,170
2019-01-14 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 93.79 375,160
2019-01-14 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2019-01-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 90.55 271,650
2019-01-10 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 14.39 43,170
2019-01-08 Bienaime Jean Jacques (Chief Executive Officer) Sale 6,000 91.48 548,856
2019-01-08 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 6,000 14.39 86,340
2019-01-07 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 87.58 262,740
2019-01-07 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 14.39 43,170
2018-12-28 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 84.04 252,120
2018-12-28 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 14.39 43,170
2018-12-27 Lawlis V Bryan Sale 2,150 82.53 177,439
2018-12-27 Lawlis V Bryan Option Ex 2,150 14.39 30,938
2018-12-26 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 80.50 322,000
2018-12-26 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2018-12-14 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 92.64 185,280
2018-12-14 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 17.86 35,720
2018-12-12 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 93.12 186,240
2018-12-12 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 17.86 35,720
2018-11-14 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 9,000 93.00 836,973
2018-11-14 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Option Ex 9,000 63.10 567,900
2018-11-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,500 97.88 146,820
2018-11-02 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,500 17.86 26,790
2018-11-01 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 92.55 370,200
2018-11-01 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 14.39 57,560
2018-10-30 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 14.39 14,390
2018-10-24 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 14.39 14,390
2018-10-03 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 1,000 98.98 98,985
2018-10-03 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,500 99.36 149,040
2018-10-03 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,500 17.86 26,790
2018-09-27 Lawlis V Bryan Sale 2,150 97.93 210,549
2018-09-27 Lawlis V Bryan Option Ex 2,150 14.39 30,938
2018-09-25 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 14.39 14,390
2018-09-14 Davis George Eric (EVP, General Counsel) Sale 2,216 99.45 220,390
2018-09-13 Davis George Eric (EVP, General Counsel) Sale 12,000 99.57 1,194,840
2018-09-13 Meier Richard A Sale 3,000 99.25 297,735
2018-09-13 Meier Richard A Option Ex 15,000 21.51 322,650
2018-09-05 Heron Elaine J Sale 1,000 96.94 96,935
2018-09-04 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,500 98.16 147,240
2018-09-04 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,500 17.86 26,790
2018-08-28 Lewis Alan Sale 7,500 99.11 743,362
2018-08-28 Lewis Alan Option Ex 7,500 14.39 107,925
2018-08-27 Meier Richard A Sale 2,000 100.12 200,236
2018-08-27 Meier Richard A Option Ex 15,000 14.39 215,850
2018-08-27 Fuchs Henry J (President, Worldwide R&D) Sale 12,500 100.00 1,250,000
2018-08-24 Fuchs Henry J (President, Worldwide R&D) Sale 12,500 99.00 1,237,500
2018-08-21 Lewis Alan Sale 4,200 100.09 420,365
2018-08-07 Baffi Robert (EVP, Technical Operations) Sale 5,173 105.00 543,165
2018-07-23 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,500 101.69 152,535
2018-07-23 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,500 17.86 26,790
2018-06-27 Lawlis V Bryan Sale 2,150 93.52 201,068
2018-06-27 Lawlis V Bryan Option Ex 2,150 14.39 30,938
2018-06-22 Mueller Brian (SVP, Corporate Controller) Sale 3,145 99.50 312,927
2018-06-22 Mueller Brian (SVP, Corporate Controller) Option Ex 2,491 28.23 70,320
2018-06-22 Baffi Robert (EVP, Technical Operations) Sale 6,949 99.00 687,985
2018-06-22 Baffi Robert (EVP, Technical Operations) Option Ex 6,949 14.39 99,996
2018-06-22 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 10,000 99.00 990,050
2018-06-15 Mueller Brian (SVP, Corporate Controller) Sale 2,021 94.50 190,984
2018-06-14 Fuchs Henry J (President, Worldwide R&D) Sale 31,000 90.00 2,790,031
2018-06-14 Fuchs Henry J (President, Worldwide R&D) Option Ex 31,000 29.88 926,342
2018-06-13 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 14.39 14,390
2018-06-11 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 1,436 90.31 129,685
2018-05-17 Meier Richard A Option Ex 15,000 38.59 578,850
2018-05-17 Bienaime Jean Jacques (Chief Executive Officer) Sale 18,750 88.66 1,662,356
2018-05-17 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 18,750 38.59 723,562
2018-05-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 18,750 89.13 1,671,131
2018-05-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 18,750 38.59 723,562
2018-05-15 Bienaime Jean Jacques (Chief Executive Officer) Sale 18,750 88.29 1,655,437
2018-05-15 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 18,750 38.59 723,562
2018-05-14 Bienaime Jean Jacques (Chief Executive Officer) Sale 18,750 89.22 1,672,856
2018-05-14 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 18,750 38.59 723,562
2018-05-11 Bienaime Jean Jacques (Chief Executive Officer) Sale 18,750 88.42 1,657,856
2018-05-11 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 18,750 38.59 723,562
2018-05-10 Mueller Brian (SVP, Corporate Controller) Sale 2,450 89.50 219,275
2018-05-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 18,750 89.59 1,679,793
2018-05-10 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 18,750 38.59 723,562
2018-05-07 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 309 85.96 26,561
2018-04-24 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 82.29 822,890
2018-04-24 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 38.59 385,900
2018-04-23 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 11,059 82.15 908,496
2018-04-23 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 82.58 825,810
2018-04-23 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 38.59 385,900
2018-04-20 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 83.65 836,460
2018-04-20 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 38.59 385,900
2018-04-17 Lawlis V Bryan Sale 3,750 85.00 318,750
2018-04-17 Lawlis V Bryan Option Ex 3,750 38.59 144,712
2018-04-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 14.39 14,390

Insider trading activities including stock purchases, stock sales, and option exercises of BMRN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biomarin Pharmaceutical Inc (symbol BMRN, CIK number 1048477) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month